210 related articles for article (PubMed ID: 10381773)
1. SIB-1757 and SIB-1893: selective, noncompetitive antagonists of metabotropic glutamate receptor type 5.
Varney MA; Cosford ND; Jachec C; Rao SP; Sacaan A; Lin FF; Bleicher L; Santori EM; Flor PJ; Allgeier H; Gasparini F; Kuhn R; Hess SD; Veliçelebi G; Johnson EC
J Pharmacol Exp Ther; 1999 Jul; 290(1):170-81. PubMed ID: 10381773
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of the actions of group I metabotropic glutamate receptor subtype selective ligands on excitatory amino acid release and sodium-dependent re-uptake in rat cerebrocortical minislices.
Fazal A; Parker F; Palmer AM; Croucher MJ
J Neurochem; 2003 Sep; 86(6):1346-58. PubMed ID: 12950444
[TBL] [Abstract][Full Text] [Related]
3. Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism.
O'Leary DM; Movsesyan V; Vicini S; Faden AI
Br J Pharmacol; 2000 Dec; 131(7):1429-37. PubMed ID: 11090117
[TBL] [Abstract][Full Text] [Related]
4. mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors.
Movsesyan VA; O'Leary DM; Fan L; Bao W; Mullins PG; Knoblach SM; Faden AI
J Pharmacol Exp Ther; 2001 Jan; 296(1):41-7. PubMed ID: 11123360
[TBL] [Abstract][Full Text] [Related]
5. Selective blockade of metabotropic glutamate receptor subtype 5 is neuroprotective.
Bruno V; Ksiazek I; Battaglia G; Lukic S; Leonhardt T; Sauer D; Gasparini F; Kuhn R; Nicoletti F; Flor PJ
Neuropharmacology; 2000 Sep; 39(12):2223-30. PubMed ID: 10974306
[TBL] [Abstract][Full Text] [Related]
6. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist.
Gasparini F; Lingenhöhl K; Stoehr N; Flor PJ; Heinrich M; Vranesic I; Biollaz M; Allgeier H; Heckendorn R; Urwyler S; Varney MA; Johnson EC; Hess SD; Rao SP; Sacaan AI; Santori EM; Veliçelebi G; Kuhn R
Neuropharmacology; 1999 Oct; 38(10):1493-503. PubMed ID: 10530811
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.
Lea PM; Movsesyan VA; Faden AI
Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750
[TBL] [Abstract][Full Text] [Related]
8. Cloning and stable expression of the mGluR1b subtype of human metabotropic receptors and pharmacological comparison with the mGluR5a subtype.
Lin FF; Varney M; Sacaan AI; Jachec C; Daggett LP; Rao S; Flor P; Kuhn R; Kerner JA; Standaert D; Young AB; Veliçelebi G
Neuropharmacology; 1997 Jul; 36(7):917-31. PubMed ID: 9257936
[TBL] [Abstract][Full Text] [Related]
9. CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding.
Litschig S; Gasparini F; Rueegg D; Stoehr N; Flor PJ; Vranesic I; Prézeau L; Pin JP; Thomsen C; Kuhn R
Mol Pharmacol; 1999 Mar; 55(3):453-61. PubMed ID: 10051528
[TBL] [Abstract][Full Text] [Related]
10. The non-competitive antagonists 2-methyl-6-(phenylethynyl)pyridine and 7-hydroxyiminocyclopropan[b]chromen-1a-carboxylic acid ethyl ester interact with overlapping binding pockets in the transmembrane region of group I metabotropic glutamate receptors.
Pagano A; Ruegg D; Litschig S; Stoehr N; Stierlin C; Heinrich M; Floersheim P; Prezèau L; Carroll F; Pin JP; Cambria A; Vranesic I; Flor PJ; Gasparini F; Kuhn R
J Biol Chem; 2000 Oct; 275(43):33750-8. PubMed ID: 10934211
[TBL] [Abstract][Full Text] [Related]
11. Sustained activation of metabotropic glutamate receptor 5 and protein tyrosine phosphatases mediate the expression of (S)-3,5-dihydroxyphenylglycine-induced long-term depression in the hippocampal CA1 region.
Huang CC; Hsu KS
J Neurochem; 2006 Jan; 96(1):179-94. PubMed ID: 16277605
[TBL] [Abstract][Full Text] [Related]
12. Both mGluR1 and mGluR5 mediate Ca2+ release and inward currents in hippocampal CA1 pyramidal neurons.
Rae MG; Irving AJ
Neuropharmacology; 2004 Jun; 46(8):1057-69. PubMed ID: 15111012
[TBL] [Abstract][Full Text] [Related]
13. Selective induction of metabotropic glutamate receptor 1- and metabotropic glutamate receptor 5-dependent chemical long-term potentiation at oriens/alveus interneuron synapses of mouse hippocampus.
Le Vasseur M; Ran I; Lacaille JC
Neuroscience; 2008 Jan; 151(1):28-42. PubMed ID: 18035501
[TBL] [Abstract][Full Text] [Related]
14. A novel, competitive mGlu(5) receptor antagonist (LY344545) blocks DHPG-induced potentiation of NMDA responses but not the induction of LTP in rat hippocampal slices.
Doherty AJ; Palmer MJ; Bortolotto ZA; Hargreaves A; Kingston AE; Ornstein PL; Schoepp DD; Lodge D; Collingridge GL
Br J Pharmacol; 2000 Sep; 131(2):239-44. PubMed ID: 10991916
[TBL] [Abstract][Full Text] [Related]
15. Group 1 mGlu receptors elevate [Ca2+]i in rat cultured cortical type 2 astrocytes: [Ca2+]i synergy with adenosine A1 receptors.
Toms NJ; Roberts PJ
Neuropharmacology; 1999 Oct; 38(10):1511-7. PubMed ID: 10530813
[TBL] [Abstract][Full Text] [Related]
16. Regulation of phosphoinositide turnover in neonatal rat cerebral cortex by group I- and II- selective metabotropic glutamate receptor agonists.
Mistry R; Golding N; Challiss RA
Br J Pharmacol; 1998 Feb; 123(3):581-9. PubMed ID: 9504400
[TBL] [Abstract][Full Text] [Related]
17. Modulation of intracellular calcium mobilization and GABAergic currents through subtype-specific metabotropic glutamate receptors in neonatal rat hippocampus.
Taketo M; Matsuda H
Brain Res Bull; 2010 Jan; 81(1):73-80. PubMed ID: 19628026
[TBL] [Abstract][Full Text] [Related]
18. Differential roles for mGluR1 and mGluR5 in the persistent prolongation of epileptiform bursts.
Merlin LR
J Neurophysiol; 2002 Jan; 87(1):621-5. PubMed ID: 11784776
[TBL] [Abstract][Full Text] [Related]
19. Metabotropic glutamate receptor 5 responses dictate differentiation of neural progenitors to NMDA-responsive cells in fragile X syndrome.
Achuta VS; Grym H; Putkonen N; Louhivuori V; Kärkkäinen V; Koistinaho J; Roybon L; Castrén ML
Dev Neurobiol; 2017 Apr; 77(4):438-453. PubMed ID: 27411166
[TBL] [Abstract][Full Text] [Related]
20. Methylphenylethynylpyridine (MPEP) Novartis.
Micheli F
Curr Opin Investig Drugs; 2000 Nov; 1(3):355-9. PubMed ID: 11249719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
